Combination therapy with a long-acting amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist results in ...

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

Detailed Phase IIIb STEP UP trial results presented at the 2025 ADA Scientific Sessions found that an investigational 7.2 mg dose of Wegovy (semaglutide) led to a mean weight loss of 21% in adults ...

Flash forward to today however, and Weight Watchers has filed for bankruptcy while weight loss jabs like Mounjaro, Ozempic, ...

In a new TikTok video, the consultant and professor explains who's really eligible and why BMI isn't the full story ...

BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...

Foods high in protein, fiber, and micronutrients like magnesium—such as beans, lentils and seafood—can help keep your blood ...

The three abstracts have been published in Diabetes, the peer-reviewed journal of the American Diabetes Association. Biomea remains committed to advancing novel therapies that improve patient outcomes ...